CME Group (NQ:CME)

304.52 -1.37 (-0.45%)

Delayed Quote Updated: 4:00 PM EST, Nov 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CME Group

< Previous 1 2 3 4 5 6 7 8 9

...

30 31 Next >

Markets Are Pricing in a Fed Rate Hike in December. Here's What Investors Should Do, According to History. ↗

November 08, 2026

Another Fed rate hike looks likely. If history is any guide, investors will want to take four steps.

Via The Motley Fool

Topics Bonds ETFs Economy

S&P 500 After-Hours Movers: ABNB and SNDK Gain, AXON and SOLV Fall ↗

November 05, 2026

Via Chartmill

Topics Stocks

Prediction: A Stock Market Crash Is Coming. Here's What Investors Should Do Based on Nearly 70 Years' Worth of History. ↗

November 05, 2026

A growing chorus of risks could send the S&P 500 stock market index tumbling.

Via The Motley Fool

Topics Artificial Intelligence Economy Energy

CME vs. Nu: Which Financial Stock Is a Better Buy for 2027? ↗

November 04, 2026

CME boasts a 62% net margin and fortress balance sheet, while Nu's 43% revenue growth signals emerging-market momentum, but their risk profiles diverge sharply.

Via The Motley Fool

Topics Credit Cards

CME Group (NASDAQ:CME) Posts Record Q3 Revenue as Results Meet Expectations ↗

October 21, 2026

Via Chartmill

Quality Investing Spotlight: CME Group (NASDAQ:CME) Passes Key Filters but Valuation Requires Caution ↗

September 30, 2026

Via Chartmill

CME vs. Interactive Brokers Group: Which Financial Stock Is a Better Buy for 2027? ↗

November 03, 2026

CME commands a 62% net margin but trades at a higher sales multiple, while Interactive Brokers posts stronger free cash flow despite lower profitability.

Via The Motley Fool

Topics Derivatives

CME Group's Market Data Revenue Hit a Record $243 Million Last Quarter. Can It Carry the Stock When Trading Slows? ↗

November 03, 2026

The narrative is bullish, but numbers (and pictures) are needed to put it in proper perspective.

Via The Motley Fool

1 momentum stock with exciting potential and 2 we avoid

November 02, 2026

Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a ne...

Via StockStory

Topics Derivatives

CME vs. SoFi Technologies: Which Financial Stock Is a Better Buy for 2027? ↗

November 02, 2026

CME boasts a fortress balance sheet and a 62% net margin, while SoFi is burning cash but growing revenue 28.8% annually, a classic stability-versus-growth showdown.

Via The Motley Fool

Topics Derivatives

CME vs. Morningstar: Scale vs. Consistent Trajectories in Revenue ↗

October 30, 2026

CME commands a 2.5x revenue advantage, but Morningstar's unbroken eight-quarter growth streak tells a different story about momentum.

Via The Motley Fool

CME vs. Mastercard: Which Financial Stock Is a Better Buy in 2026? ↗

October 27, 2026

CME boasts a 62% net margin and minimal debt, while Mastercard captures 16% revenue growth with $16.4B in free cash flow.

Via The Motley Fool

Topics Derivatives Economy

October 27, 2026

Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cord...

Via StockStory

Topics Derivatives

Here's Exactly What Investors Should Look for From the Federal Reserve's October Meeting ↗

October 26, 2026

Don't worry too much about it either way, whether or not the interest rate decision works for you or against you.

Via The Motley Fool

Topics Bonds Economy

Q3 Earnings: Review Quarterly, Manage Accordingly ↗

October 26, 2026

The last of six Rule Breakers Principles is built for this stretch: Review quarterly, manage accordingly.

Via The Motley Fool

Topics Artificial Intelligence Derivatives

CME Group vs. Coinbase Global: Steady Growth Meets Crypto's Boom-and-Bust Cycle ↗

October 26, 2026

Coinbase's revenue has fallen nearly 50% over two years while CME has held steady—a divergence that raises questions about their competitive positioning.

Via The Motley Fool

Topics Derivatives

The Latest Inflation Data Spells Bad News for Fed Chair Kevin Warsh and the Stock Market ↗

October 22, 2026

The stock market looks especially vulnerable to a sharp correction right now.

Via The Motley Fool

Topics Economy

CME Q3 deep dive: diversified volume growth and product innovation underpin results

October 22, 2026

Financial derivatives exchange CME Group (NASDAQ:CME) announced better-than-expected revenue in Q3 2026, with sales up 13% year on year to $1.74 billion. Its...

Via StockStory

Topics Derivatives Economy

CME Group: 3 Key Takeaways for Long-Term Investors ↗

October 21, 2026

Market data has now grown for 34 straight quarters, cementing a predictable revenue engine independent of trading swings.

Via The Motley Fool

Topics Derivatives Earnings Economy

CME (CME) Q3 2026 Earnings Call Transcript ↗

October 21, 2026

Record revenue and trading volumes drove 13% EPS growth as international markets surged.

Via The Motley Fool

Topics Earnings

CME Group Q3 Earnings Call Highlights ↗

October 21, 2026

CME Group (NASDAQ:CME) reported record third-quarter activity and financial results, citing broad-based demand for risk-management products amid shifting central-bank policies, geopolitical uncertainty...

Via MarketBeat

Topics Earnings Economy

CME Group (NASDAQ:CME) Surprises With Q3 2026 Sales

October 21, 2026

Financial derivatives exchange CME Group (NASDAQ:CME) reported Q3 2026 results beating Wall Street’s revenue expectations, with sales up 13% year on year to ...

Via StockStory

Topics Derivatives

CME Group (CME) Reports Earnings Tomorrow: What To Expect

October 19, 2026

Financial derivatives exchange CME Group (NASDAQ:CME) will be announcing earnings results this Wednesday morning. Here’s what to expect. CME Group beat analy...

Via StockStory

Topics Artificial Intelligence Derivatives Economy

CME vs. Coinbase Global: Which Financial Stock Is a Better Buy in 2026? ↗

October 19, 2026

CME trades at a cheaper earnings multiple with fortress-like margins, while Coinbase scales faster but carries regulatory uncertainty.

Via The Motley Fool

Topics Derivatives

The Stock Market Is Facing 3 Huge Problems Right Now, and History Is Clear About What's Coming ↗

October 15, 2026

Volatility could be coming, but history has good news for investors.

Via The Motley Fool

Topics Artificial Intelligence Bonds Credit Cards

CME vs. Morningstar: Which Financial Stock Is a Better Buy in 2026? ↗

October 13, 2026

CME Group earns a net margin of about 62% and carries little debt, and Morningstar trades at a lower valuation but has taken on debt while repurchasing shares and acquiring CRSP.

Via The Motley Fool

Topics Derivatives Regulatory Compliance

CME vs. Robinhood Markets: Which Financial Stock Is a Better Buy in 2026? ↗

October 13, 2026

CME offers steady compounding through market infrastructure, while Robinhood offers faster growth with more volatility.

Via The Motley Fool

Topics Derivatives

Record French Debt Could Create Opportunities for U.S. Market Operators ↗

October 06, 2026

France's rising debt and widening bond yields could drive derivatives trading volumes higher, potentially benefiting U.S. exchange operators CME Group and Intercontinental Exchange.

Via MarketBeat

Topics Bonds Derivatives Economy

CME vs. Robinhood Markets: Which Financial Stock Is a Better Buy in 2026? ↗

September 29, 2026

CME's 62% net margin and fortress balance sheet contrast sharply with Robinhood's 51% revenue growth and regulatory headwinds.

Via The Motley Fool

Topics Derivatives

Discover which S&P500 stocks are making waves on Friday. ↗

September 25, 2026

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9

...

30 31 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.